Phase II study of biweekly Gemcitabine and Docetaxel as first line treatment for advanced disease in elderly Non Small Cell Lung Cancer (NSCLC) patients

被引：0
|
作者：
Munoz-Langa, Jose [1 ]
Sanchez-Hernandez, Alfredo [2 ]
Gomez-Codina, Jose [3 ]
Esquerdo, Gaspar [4 ]
Catot, Silvia [5 ]
Macia, Sonia [6 ]
Juan, Oscar [7 ]
Giner, Vicente [8 ]
机构：
[1] Hosp Doctor Peset, Serv Oncol, Valencia, Spain
[2] Hosp Prov Castellon, Castellon de La Plana, Spain
[3] Hosp La Fe, E-46009 Valencia, Spain
[4] Hosp Clin Benidorm, Benidorm, Spain
[5] Hosp Althaia Xarxa Asitencial Manresa, Manresa, Spain
[6] Hosp Elda, Elda, Spain
[7] Hosp Arnau Vilanova, Valencia, Spain
[8] Hosp Sagunto, Sagunto, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S700 / S701
页数：2
相关论文
共 50 条
  • [1] Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in elderly non-small cell lung cancer (NSCLC) patients.
    Llorca, C.
    Esquerdo, G.
    Munoz, J., Sr.
    Sanchez-Hernandez, A.
    Gomez-Codina, J.
    Juan Vidal, O.
    Macia, S.
    Catot, S.
    Giner, V.
    Aparisi, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gaspar, E.
    Firvida, J.
    Amenedo, M.
    Orts, D.
    Salgado, M.
    LLorca, C.
    Ramos, M.
    Perez, E.
    Cervera, J.
    Abal, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: A phase II study
    Syrigos, K. N.
    Karapanagiotou, E.
    Charpidou, A.
    Dilana, K.
    Dannos, I.
    Dionellis, G.
    Rigopoulou, A.
    Georgatou, N.
    Roussos, C.
    [J]. JOURNAL OF CHEMOTHERAPY, 2007, 19 (04) : 438 - 443
  • [4] Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in non-small cell lung cancer (NSCLC) patients with ECOG performance status 2.
    Giner, V.
    Juan Vidal, O.
    Munoz, J., Sr.
    Esquerdo, G.
    Sanchez-Hernandez, A.
    Gomez-Codina, J.
    Aparisi, F.
    Macia, S.
    Lopez Jimenez, A.
    Catot, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] First line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study
    Lo Dico, M.
    Vasile, E.
    Tibaldi, C.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Mazzoni, E.
    Andreuccetti, M.
    D'Alessandro, M.
    Nacci, A.
    Falcone, A.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 35 - 35
  • [6] Biweekly docetaxel and carboplatin as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC). Finally results of a phase II study
    Firvida, J. L.
    Esquerdo, G.
    Amenedo, M.
    Salgado, M.
    LLorca, C.
    Perez, E.
    Cervera Grau, J.
    Ramos, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] First-line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: a multicenter phase II study
    Tibaldi, C.
    Vasile, E.
    Lo Dico, M.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Mazzoni, E.
    Andreuccetti, M.
    Falcone, A.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 176 - 176
  • [8] Biweekly docetaxel and carboplatin ase first line chemotherapy in advanced non small cell lung cancer (NSCLC)
    Firvida, Jose L.
    Esquerdo, Gaspar
    Amenedo, Margarita
    Salgado, Mercedes
    Llorca, Cristina
    Ramos, Manuel
    Perez, Eva
    Cervera, Jose M.
    Gomez, Jesus Garcia
    Mata, Jesus Garcia
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 224 - 225
  • [9] Phase II study of biweekly carboplatin and paclitaxel as first-line treatment for elderly patients with advanced non-small cell lung cancer
    Terai, H.
    Soejima, K.
    Nakamura, M.
    Naoki, K.
    Yasuda, H.
    Satomi, R.
    Nakayama, S.
    Yoda, S.
    Ikemura, S.
    Sato, T.
    Asano, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Phase II study of docetaxel monotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC)
    Takigawa, N
    Segawa, Y
    Kishino, D
    Fujiwara, K
    Shinkai, T
    Watanabe, Y
    Tabata, M
    Kiura, K
    Ueoka, H
    Tanimoto, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 776S - 776S
12345